Chimera Investment Corporation Common Stock (CIM)
Fast GrowerFairStock Score: 80/100 — HIGH CONVICTION
Key Financials
| Current Price | $13.09 |
| Market Cap | $1.1B |
| P/E Ratio | -15.77 |
| ROE | 0.75% |
| Dividend Yield | 13.6% |
| Sector | Real Estate |
Strengths
- Revenue growth of 158.1% demonstrates strong top-line momentum
- Attractive 13.4% dividend yield providing steady income returns
- FairStock composite score of 80/100 places it in the top tier across value, quality, and momentum factors
Concerns
- High leverage at 5.08x debt-to-equity increases financial risk and interest expense burden
- Weak Piotroski F-Score of 3/9 suggests deteriorating financial quality across multiple dimensions
- Altman Z-Score of -0.1 places it in the financial distress zone—elevated bankruptcy risk
AI Analysis
Chimera Investment Corporation Common Stock is a micro-cap real estate company valued at $1.1 billion. The business generates $369 million in annual revenue with a 1.8% net margin. From a quality standpoint, Chimera shows weak Piotroski F-Score of 3/9 signaling deteriorating fundamentals and distressed Altman Z-Score of -0.1 warrants caution. On valuation, the stock is deeply undervalued on a P/E basis at 7.8x, with offers a 61% margin of safety vs Graham Number of $35. Growth dynamics show revenue growing at 158.1% and profit growth of 119.3%. The 13.4% dividend yield adds an income component for patient holders. Our composite FairStock Score of 80/100 reflects strong fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.
Bull Case
Chimera's 158% revenue growth trajectory could accelerate as it captures additional market share in the real estate sector. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.
Bear Case
Elevated leverage at 5.1x D/E means rising interest rates or revenue weakness could strain debt covenants and force asset sales at distressed prices. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer